Supriya Lifescience [SUPRIYA] vs Biocon [BIOCON] Detailed Stock Comparison

Supriya Lifescience Ltd.

NSE
Loading...

Biocon Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Supriya Lifescience Ltd. wins in 11 metrics, Biocon Ltd. wins in 9 metrics, with 0 ties. Supriya Lifescience Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Supriya Lifescience Ltd. Biocon Ltd. Better
P/E Ratio (TTM) 27.94 71.84 Supriya Lifescience Ltd.
Price-to-Book Ratio 4.78 1.68 Biocon Ltd.
Debt-to-Equity Ratio 0.48 50.02 Supriya Lifescience Ltd.
PEG Ratio 4.65 0.17 Biocon Ltd.
EV/EBITDA 19.44 19.22 Biocon Ltd.
Profit Margin (TTM) 25.19% 3.59% Supriya Lifescience Ltd.
Operating Margin (TTM) 31.61% 7.63% Supriya Lifescience Ltd.
EBITDA Margin (TTM) 31.61% 7.63% Supriya Lifescience Ltd.
Return on Equity 18.86% 3.66% Supriya Lifescience Ltd.
Return on Assets (TTM) 16.90% 1.72% Supriya Lifescience Ltd.
Free Cash Flow (TTM) $22.99M $17.18B Biocon Ltd.
Dividend Yield 0.27% 0.26% Supriya Lifescience Ltd.
1-Year Return 41.71% 17.90% Supriya Lifescience Ltd.
Price-to-Sales Ratio (TTM) 7.03 3.37 Biocon Ltd.
Enterprise Value $50.78B $643.51B Biocon Ltd.
EV/Revenue Ratio 6.90 3.82 Biocon Ltd.
Gross Profit Margin (TTM) 70.35% 67.91% Supriya Lifescience Ltd.
Revenue per Share (TTM) $91 $133 Biocon Ltd.
Earnings per Share (Diluted) $23.01 $4.87 Supriya Lifescience Ltd.
Beta (Stock Volatility) 0.28 0.25 Biocon Ltd.

Supriya Lifescience Ltd. vs Biocon Ltd. Stock Performance Analysis

Loading Price Chart...

SUPRIYA
BIOCON

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Supriya Lifescience Ltd.-2.25%3.93%38.73%66.47%32.20%28.93%
Biocon Ltd.-0.70%1.66%-3.27%10.34%6.50%7.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Supriya Lifescience Ltd.41.71%283.42%102.02%102.02%102.02%102.02%
Biocon Ltd.17.90%71.09%5.03%250.57%603.49%1,357.39%

Performance & Financial Health Analysis: Supriya Lifescience Ltd. vs Biocon Ltd.

MetricSUPRIYABIOCON
Market Information
Market Cap i₹51.74B₹566.52B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i200,0972,496,867
90 Day Avg. Volume i176,2313,790,310
Last Close₹955.20₹416.05
52 Week Range₹545.50 - ₹1,085.00₹331.00 - ₹440.40
% from 52W High-11.96%-5.53%
All-Time High₹1,085.00 (Jun 01, 2026)₹487.75 (Dec 21, 2020)
% from All-Time High-11.96%-14.70%
Growth Metrics
Quarterly Revenue Growth0.11%0.09%
Quarterly Earnings Growth0.06%4.73%
Financial Health
Profit Margin (TTM) i0.25%0.04%
Operating Margin (TTM) i0.32%0.08%
Return on Equity (TTM) i0.19%0.04%
Debt to Equity (MRQ) i0.4850.02
Cash & Liquidity
Book Value per Share (MRQ)₹134.51₹207.92
Cash per Share (MRQ)₹12.82₹45.84
Operating Cash Flow (TTM) i₹1.87B₹17.78B
Levered Free Cash Flow (TTM) i₹1.88B₹10.13B
Dividends
Last 12-Month Dividend Yield i0.27%0.26%
Last 12-Month Dividend i₹1.80₹1.00

Valuation & Enterprise Metrics Analysis: Supriya Lifescience Ltd. vs Biocon Ltd.

MetricSUPRIYA (Apr 26, 2026)BIOCON (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i27.9471.84
Forward P/E i20.9738.56
PEG Ratio i4.650.17
Price to Sales (TTM) i7.033.37
Price to Book (MRQ) i4.781.68
Market Capitalization
Market Capitalization i₹51.74B₹566.52B
Enterprise Value i₹50.78B₹643.51B
Enterprise Value Metrics
Enterprise to Revenue i6.903.82
Enterprise to EBITDA i19.4419.22
Risk & Other Metrics
Beta i0.280.25
Book Value per Share (MRQ) i₹134.51₹207.92

Financial Statements Comparison: Supriya Lifescience Ltd. vs Biocon Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSUPRIYA (2025)BIOCON (2025)
Revenue/Sales i6.80B150.52B
Cost of Goods Sold i2.86B51.98B
COGS % of Revenue i42.1%34.5%
Gross Profit i3.93B98.54B
Gross Margin i57.9%65.5%
Research & Development iN/A6.34B
Operating Income (EBIT) i2.36B16.26B
Operating Margin i34.7%10.8%
EBITDA i2.66B33.60B
EBITDA Margin i39.2%22.3%
Pre-Tax Income i2.48B18.87B
Pre-Tax Income % of Revenue i36.6%12.5%
Income Tax i605.23M4.57B
Income Tax % of Revenue i8.9%3.0%
Net Income (Profit) i1.88B14.29B
Profit Margin i27.7%9.5%

Balance Sheet & Liquidity Metrics

MetricSUPRIYA (2025)BIOCON (2025)
Cash & Equivalents i759.97M32.27B
Total Current Assets i4.37B162.86B
Total Current Assets % of Revenue i64.3%108.2%
Total Current Liabilities i821.62M143.34B
Total Current Liabilities % of Revenue i12.1%95.2%
Long-Term Debt i50.57M129.45B
Long-Term Debt % of Revenue i0.7%86.0%
Total Shareholders Equity i9.97B277.13B
Retained Earnings i7.82B189.59B
Retained Earnings % of Revenue i115.1%126.0%
Property, Plant & Equipment i645.91M4.32B

Cash Flow Statement Comparison

MetricSUPRIYA (2025)BIOCON (2025)
Operating Cash Flow i1.87B17.78B
Operating Cash Flow % of Revenue i27.6%11.8%
Capital Expenditures i-1.62B-21.36B
Free Cash Flow i22.99M17.18B
FCF Margin i0.3%11.4%
Debt Repayment iN/A-97.70B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSUPRIYABIOCON
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i80.48M1.62B
Float Shares i25.52M583.07M
% Held by Insiders i70.84%54.07%
% Held by Institutions i4.42%24.88%
% Held by Public i24.74%21.05%

Dividend Analysis & Yield Comparison: Supriya Lifescience Ltd. vs Biocon Ltd.

MetricSUPRIYABIOCON
Last 12-Month Dividend i₹1.80₹1.00
Last 12-Month Dividend Yield i0.27%0.26%
3-Year Avg Annual Dividend i₹0.80₹1.33
3-Year Avg Dividend Yield i0.17%0.36%
3-Year Total Dividends i₹2.40₹4.00
Ex-Dividend DateSep 04, 2025Jul 04, 2025